Literature DB >> 25416657

Estimated GFR or albuminuria: which one is really associated with resistant hypertension?

César A Romero1, Aldo J Peixoto2, Marcelo Orias3.   

Abstract

Patients with resistant hypertension belong to a very high cardiovascular risk group and have a high prevalence of target organ damage. Microalbuminuria and low estimated glomerular filtration rate are associated with resistant hypertension, and could be a cause and/or complication of hypertension. In this review, we explore the relationship between these 2 markers of kidney disease and the prevalence of resistant hypertension. We identified different phenotypes of resistant hypertension that associate with microalbuminuria and/or low estimated glomerular filtration rate. These phenotypes suggest that high sympathetic activity associated with fluid overload and endothelial dysfunction may contribute differently to the development of resistant hypertension.

Entities:  

Keywords:  Resistant hypertension; endothelial dysfunction; glomerular filtration rate; microalbuminuria

Mesh:

Year:  2014        PMID: 25416657     DOI: 10.1016/j.semnephrol.2014.08.002

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  3 in total

1.  Prognostic impact of baseline urinary albumin excretion rate in patients with resistant hypertension: a prospective cohort study.

Authors:  Paula Moreira da Costa; Arthur Fernandes Cortez; Fabio de Souza; Gabriel de Souza Mares; Bruno Dussoni Moreira Dos Santos; Elizabeth Silaid Muxfeldt
Journal:  J Hum Hypertens       Date:  2017-12-11       Impact factor: 3.012

Review 2.  A Novel Mechanism of Renal Microcirculation Regulation: Connecting Tubule-Glomerular Feedback.

Authors:  Cesar A Romero; Oscar A Carretero
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

3.  Urine Albumin/Creatinine Ratio Below 30 mg/g is a Predictor of Incident Hypertension and Cardiovascular Mortality.

Authors:  Ki-Chul Sung; Seungho Ryu; Jong-Young Lee; Sung Ho Lee; EunSun Cheong; Young-Youl Hyun; Kyu-Beck Lee; Hyang Kim; Christopher D Byrne
Journal:  J Am Heart Assoc       Date:  2016-09-13       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.